FindTrial
Sign In

Association between the way of maintenance iron supplementation and hemoglobin variability in hemodialysis patients

Association between the way of maintenance iron supplementation and hemoglobin variability in hemodialysis patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16008897
Enrollment
Unknown
Registered
2016-07-24
Start date
2016-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end stage renal failure

Interventions

1:Oral iron supplemation
2:Venue supplementation

Sponsors

Division of Nephrology, Zhongshan Hospital, Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. MHD duration=3 months, 2-3 times per week; 2. at initial phase, patients with Hb 110g/L to 130g/L, TSAT 30% to 50%, SF 500ug/L to 800ug/L; 3. receive a steady dose of ESAs; 4. aged 18 to 75 years old.

Exclusion criteria

Exclusion criteria: serious cardiac and/or pulmonary insufficiency, tumor,bleeding, malnutrition, pregnancy and breastfeeding

Design outcomes

Primary

MeasureTime frame
hemoglobin;—

Countries

China

Contacts

Public ContactYingying Chen

Division of Nephrology, Zhongshan Hospital, Xiamen University

elaine_chenyy@hotmail.com+86 18950036890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026